Laboratorio Reig (RJF) | Financial Analysis & Statements
Laboratorio Reig Jofre S.A. | Mid-cap | Healthcare
Laboratorio Reig Jofre S.A. | Mid-cap | Healthcare
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
338.9M
Gross Profit
195.7M
57.74%
Operating Income
15.1M
4.45%
Net Income
10.5M
3.09%
EPS (Diluted)
€0.13
Balance Sheet Metrics
Total Assets
344.9M
Total Liabilities
130.9M
Shareholders Equity
214.0M
Debt to Equity
0.61
Cash Flow Metrics
Operating Cash Flow
7.6M
Free Cash Flow
10.6M
Revenue & Profitability Trend
Laboratorio Reig Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 338.9M | 316.1M | 271.2M | 236.2M | 230.1M |
| Cost of Goods Sold | 143.2M | 137.1M | 113.8M | 91.3M | 89.7M |
| Gross Profit | 195.7M | 179.0M | 157.3M | 145.0M | 140.4M |
| Operating Expenses | 69.7M | 67.4M | 56.8M | 53.2M | 47.4M |
| Operating Income | 15.1M | 12.4M | 9.2M | 9.4M | 9.9M |
| Pre-tax Income | 11.8M | 10.5M | 8.8M | 5.8M | 6.4M |
| Income Tax | 1.4M | 1.1M | 658.0K | 713.0K | 760.0K |
| Net Income | 10.5M | 9.4M | 8.1M | 5.1M | 5.7M |
| EPS (Diluted) | €0.13 | €0.12 | €0.10 | €0.07 | €0.07 |
Income Statement Trend
Laboratorio Reig Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 149.7M | 132.6M | 112.3M | 108.8M | 100.7M |
| Non-Current Assets | 195.2M | 198.0M | 208.9M | 216.1M | 216.4M |
| Total Assets | 344.9M | 330.5M | 321.2M | 325.0M | 317.2M |
| Liabilities | |||||
| Current Liabilities | 82.1M | 90.2M | 75.6M | 74.9M | 77.8M |
| Non-Current Liabilities | 48.8M | 36.1M | 51.0M | 61.5M | 54.9M |
| Total Liabilities | 130.9M | 126.3M | 126.6M | 136.5M | 132.7M |
| Equity | |||||
| Total Shareholders Equity | 214.0M | 204.3M | 194.6M | 188.5M | 184.5M |
Balance Sheet Composition
Laboratorio Reig Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 11.8M | 10.5M | 8.8M | 5.8M | 6.4M |
| Operating Cash Flow | 7.6M | -8.9M | -4.4M | -6.2M | -490.0K |
| Investing Activities | |||||
| Capital Expenditures | -20.3M | -12.5M | -10.8M | -19.1M | -11.8M |
| Investing Cash Flow | -31.4M | -12.6M | -12.3M | -34.2M | -27.1M |
| Financing Activities | |||||
| Dividends Paid | -25.0K | -41.0K | -53.0K | -55.0K | -88.0K |
| Financing Cash Flow | 5.6M | -7.2M | -2.0M | 13.7M | 9.6M |
| Free Cash Flow | 10.6M | 6.3M | 4.7M | -5.3M | 6.6M |
Cash Flow Trend
Laboratorio Reig Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
23.54
Forward P/E
14.57
Price to Book
1.16
Price to Sales
0.73
PEG Ratio
14.57
Profitability Ratios
Profit Margin
3.19%
Operating Margin
4.29%
Return on Equity
5.11%
Return on Assets
2.51%
Financial Health
Current Ratio
1.80
Debt to Equity
26.19
Beta
0.82
Per Share Data
EPS (TTM)
€0.13
Book Value per Share
€2.65
Revenue per Share
€4.23
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| rjf | 249.1M | 23.54 | 1.16 | 5.11% | 3.19% | 26.19 |
| Bradespar S.A | 904.6M | 5.27 | 0.11 | 13.83% | 0.00% | 0.06 |
| Audax Renovables | 686.3M | 11.69 | 3.10 | 25.98% | 2.73% | 249.76 |
| Renta 4 Banco S.A | 667.4M | 20.76 | 4.23 | 21.49% | 13.99% | 15.20 |
| Amper S.A | 256.4M | 11.20 | 3.95 | 6.60% | 0.03% | 123.98 |
Financial data is updated regularly. All figures are in the company's reporting currency.